Changes in cardiac Aquaporin expression during aortic valve replacement surgery with cardiopulmonary bypass. (18th September 2019)

• Record Type: Journal Article
• Authors: Politi, María Teresa; Ochoa, Federico; Netti, Vanina; Ferreyra, Raúl; Bortman, Guillermo; Sanjuan, Norberto; Morales, Celina; Piazza, Antonio; Capurro, Claudia
• Is Part Of: European journal of cardio-thoracic surgery. Volume 57:Number 3(2020)
• Page Start: 556
• Page End: 564
• Publication Date: 2019-09-18
• Subjects: Aquaporins -- Cardiopulmonary bypass -- Myocardium -- Humans -- Oedema -- Aortic valve; Heart -- Surgery -- Periodicals; Chest -- Surgery -- Periodicals; 617.54
• DOI: 10.1093/ejcts/ezz249
• Languages: English
• ISSNs: 1010-7940

Abstract

Abstract: : OBJECTIVES: Cardiopulmonary bypass (CPB) use is an essential strategy for many cardiovascular surgeries. However, its use and duration have been associated with a higher rate of postoperative complications, such as low cardiac output syndrome due to myocardial oedema and dysfunction. Though Aquaporin water channels have been implicated in myocardial water balance, their specific role in this clinical scenario has not been established. METHODS: In a consecutive study of 17 patients with severe aortic stenosis undergoing aortic valve replacement surgery, 2 myocardial biopsies of the left ventricle were taken: 1 before and 1 after CPB use. Sociodemographic, clinical and laboratory data were collected. Western blot and immunohistochemistry studies were performed. RESULTS: After CPB use, there was a mean increase of ∼62% in Aquaporin 1 protein levels ( P = 0.001) and a mean reduction of ∼38% in Aquaporin 4 protein levels ( P = 0.030). In immunohistochemistry assays, Aquaporin 1 was found lining small blood vessels, while Aquaporin 4 formed a circular label in cardiomyocytes. There were no changes in the localization of either protein following CPB use. During the observed on-pump time interval, there was a 1.7%/min mean increase in Aquaporin 1 ( P = 0.021) and a 2.5%/min mean decrease in Aquaporin 4 ( P = 0.018). Myocardial interstitial oedema increased by 42% (95% confidence interval 31–54%) after CPB use. Patients who developed low cardiac output syndrome were in the upper half of the median percentage change of Aquaporin expression. CONCLUSION: Time-dependent changes in cardiac Aquaporin expression may be associated with myocardial oedema and dysfunction related to CPB use.